New research on mitochondrial function can play significant part in serious disease eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: The mitoribosome is attached to its membrane adaptor as it synthesises a bioenergetic protein (glow yellow). view more
Credit: Dan W. Nowakowski and Alexey Amunts
Scientists uncover for the first time how the body s energy makers are made using Cryo-Electron Microscopy (cryo-EM) at eBIC within Diamond which is based in Oxfordshire.
A new paper published in
Science today (19 February 2021) by an international team of researchers reports an insight into the molecular mechanism of membrane-tethered protein synthesis in mitochondria. This is a fundamental new understanding of how the human mitoribosome functions and could explain how it is affected by mutations and deregulation that lead to disorders such as deafness and diseases including cancer development.
The results lay the foundation for personalized diagnoses, which may improve treatment of severe asthma
January 20, 2021
Karolinska Institutet
In a new study, researchers at Karolinska Institutet in Sweden have used a urine test to identify and verify a patient s type of asthma.
The study, which has been published in the
American Journal of Respiratory and Critical Care Medicine, lays the foundation for a more personalized diagnosis and may result in improved treatment of severe asthma in the future.
About 10 percent of the Swedish population suffers from asthma, a disease that has become increasingly widespread over the past 50 years, with annual global mortality of around 400,000 according to the World Health Organization. Asthma is characterized by chronic inflammation in the airways, which can result in symptoms including coughing, mucous formation, and shortness of breath.
Renowned Pioneers in Ophthalmology Join SparingVision s Scientific Advisory Board
Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board
Paris, January 29, 2021 - SparingVision (the Company ), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the strengthening of its Scientific Advisory Board ( SAB ) with the appointment of internationally renowned ophthalmology pioneers Dr. Paul A. Sieving, Professor of University of California Davis School of Medicine and the former Director of the US National Eye Institute, and Prof. Botond Roska, co-director of the Institute of Molecular and Clinical Ophthalmology Basel and Professor at the Medical and Science Faculty of the University of Basel.
AE-FUNAI gets first indigenous Vice Chancellor
On
By Peter Okutu
A Professor of Medical Biochemistry who hails from Ohaukwu local government area of Ebonyi state, Prof Sunday Oge Elom has been appointed as the new Vice-Chancellor of Alex Ekwueme Federal University Ndufu-Alike, Ebonyi State.
Prof Elom’s appointment has put to an end the agitation for an indigene of Ebonyi State extraction to become the Vice-Chancellor of the Federal University.
Until his appointment which was announced through a Press Release signed by the Registrar/Secretary of Council, Odisa C. Oleke ( Mrs.) on Tuesday, 19th January, 2021, the new VC was the immediate past Deputy Vice-Chancellor, Academic of the Institution.